bremelanotide

 

Topic mentions per year

Topic mentions per year

2006-2018
02420062018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Melanocortin receptor agonists that bind to the melanocortin receptor 4 may cause increases in blood pressure (BP… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2017
2017
PURPOSE This was a Phase I study to evaluate the safety, tolerability, and hemodynamic and pharmacokinetic effects of… (More)
  • figure 1
  • figure 2
  • table II
  • table III
  • figure 3
Is this relevant?
2016
2016
AIM Evaluate efficacy/safety of bremelanotide (BMT), a melanocortin-receptor-4 agonist, to treat female sexual dysfunctions in… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2012
2012
INTRODUCTION Melanotan products are currently purchased over the Internet and are designed to induce melanogenesis to create… (More)
Is this relevant?
2008
2008
PURPOSE We evaluated the safety and efficacy of intranasal bremelanotide in men with erectile dysfunction who did not respond to… (More)
Is this relevant?
2008
2008
INTRODUCTION Sexual arousal disorder affects about 30% of women worldwide and there are no effective drug treatments for the… (More)
Is this relevant?
2008
2008
BACKGROUND AND PURPOSE Hypothalamic neuropeptides centrally modulate sexual arousal. However, the role of neuropeptides in… (More)
Is this relevant?
Review
2007
Review
2007
INTRODUCTION Bremelanotide is an analogue of the naturally occurring peptide alpha-melanocyte-stimulating hormone (alpha-MSH). It… (More)
Is this relevant?
2006
2006
INTRODUCTION Melanocortins affect multiple physiological responses, including sexual behaviors. Bremelanotide is a synthetic… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?